Catalyst Pharmaceuticals Inc (CPRX) — Cash Flow Reinvestment Rate
Catalyst Pharmaceuticals Inc (CPRX) has a Cash Flow Reinvestment Rate of 0.00x as of March 2026, reinvesting $27.00K (capex $27.00K ) from operating cash flow of $59.59 Million. Check CPRX cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Catalyst Pharmaceuticals Inc Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Catalyst Pharmaceuticals Inc across 7 annual periods. Explore Catalyst Pharmaceuticals Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Catalyst Pharmaceuticals Inc (2019–2025)
Year-by-year capital reinvestment analysis for Catalyst Pharmaceuticals Inc. For live market cap and broader valuation context, see market value of Catalyst Pharmaceuticals Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | $58.00K | $208.67 Million | $58.00K | ▼ -94.0% |
| 2024 | 0.00x | $1.11 Million | $239.81 Million | $556.00K | ▼ -99.8% |
| 2023 | 2.35x | $336.93 Million | $143.60 Million | $81.74 Million | ▲ +1313.2% |
| 2022 | 0.17x | $19.27 Million | $116.05 Million | $29.00K | ▼ -9.1% |
| 2021 | 0.18x | $11.02 Million | $60.37 Million | $1.02 Million | ▲ +63.7% |
| 2020 | 0.11x | $5.02 Million | $45.03 Million | $11.39K | ▼ -89.6% |
| 2019 | 1.08x | $37.26 Million | $34.61 Million | $19.37K | — |